Top Big Data Companies With Best Stability & Growth (2,287)

Cost & Operational Efficiency: Gross margins are far higher than the prior year and adjusted profitability improved in 2025, reflecting a disciplined shift toward higher‑margin Products and tighter spend. Management is intentionally reducing lower‑quality marketing activity to favor the Products business, supporting better unit economics.

Product Line Growth: The Products segment became the majority of revenue by mid‑2026 and showed sequential growth, with Startpage and MapQuest reporting rising sessions and site‑wide revenue. These pockets of traction indicate expanding engagement within specific product lines even as the company reshapes its mix.

Innovation-Driven Growth: New AI and agentic offerings were launched around MapQuest, Dogpile, and the IntentStream data platform, signaling ongoing product innovation. These launches are aimed at modernizing monetization and creating new growth vectors tied to owned properties.

Strong Revenue Growth: Revenue is portrayed as rising over recent years, with directional estimates indicating 2023–24 gains and Polish filings showing long‑term expansion, albeit not strictly linear. This points to continued top‑line momentum even as exact consolidated figures remain private.

Market Expansion: Operations are described across 90+ markets with 4,000+ campaigns and ongoing hiring in multiple regions, and the company states its global expansion is still gathering pace. Geographic references include teams and roles spanning the U.S., Korea, Romania, Poland and other markets.

Product Line Growth: A self‑service platform (rtb.com) launched in 2026 targets SMBs and agencies, expanding beyond the traditional enterprise focus. Offerings are also characterized as extending into DSP, CTV/OTT, first‑party advertising, and AI/Deep Learning.

Product Line Growth: Expansion from core data observability into AI/agent observability, with launches such as Observability Agents (2025), Agent Observability (2025–2026), and support for Databricks Agent Bricks, broadens the platform’s scope. Additional capabilities like machine learning metric monitors and deep ecosystem integrations reinforce product breadth.

Market Expansion: Claims of 400+ enterprise customers, monitoring of 10M tables, and ongoing publication of new enterprise deployments (e.g., Roche, Nasdaq, JetBlue, M&T Bank) indicate widening adoption. Continued enterprise case studies and category presence suggest sustained commercial reach.

Strong Revenue Growth: The company reported 100% year-over-year revenue growth in 2023 and said it added hundreds of customers that year. Earlier communications also highlighted rapid revenue expansion leading into its later-stage financing.

Strong Revenue Growth: Sales are reported to have risen from about $39 billion (2023) to more than $43 billion (2025), with 2024–2025 gains attributed to institutional solutions, whole life, and annuities.

Profitability: Operating earnings are characterized as increasing from $2.8 billion in 2024 to nearly $3.9 billion in 2025, a company‑record level.

Investor Backing & Capital Strength: Capital levels are described as strong, with total adjusted capital at $34.4 billion in 2025 and high financial‑strength ratings maintained across major agencies.

Strong Revenue Growth: Financial statements indicate total revenue rose from $499.7M in 2024 to $737.5M in 2025, with clearing‑fee revenue increasing materially over the same period. Operating data into 2026 shows elevated activity levels, consistent with continued top‑line momentum.

Profitability: Net income increased from $70.2M in 2024 to $190.7M in 2025, and operating income shifted from losses in prior years to a positive result. This reflects improved earnings alongside higher clearing volumes.

Resilient & Sustainable Growth: Contracts cleared reached record levels in 2025 and continued to expand into 2026, while the securities‑lending program also grew in value and transactions. Multi‑year trends from 2020 to 2025 show options activity more than doubling, indicating durable expansion.

Strong Market Position & Advantage: Market position is described as leading, with the largest customer base and highest revenue share among process‑mining vendors, and the highest share across major regions and buyer segments. Independent analyst assessments also continue to place the company among category leaders, pointing to durable advantage.

Innovation-Driven Growth: The company is expanding from core process mining into Process Intelligence and Enterprise AI, introducing offerings such as AgentC, AI agents, integrations, and an Orchestration Engine. Reported customer‑value milestones and ongoing platform updates suggest innovation is translating into adoption and impact.

Market Expansion: Enterprise deployments reportedly increased from more than 2,500 in 2022 to 5,000+ currently, with 1,400+ businesses served and 20+ offices. Regional traction includes progress such as capturing a majority of CAC 40 firms within five years in France.

Strong Revenue Growth: Available disclosures indicate revenue grew at a triple‑digit rate year over year in early 2026 and was later described as roughly $200M after multiple years of doubling. These signals point to rapid scaling beyond a purely funding‑led story.

Investor Backing & Capital Strength: Back‑to‑back late‑stage rounds in 2026, including a nine‑figure Series D followed quickly by a nine‑figure Series E with a stepped‑up valuation, suggest deep capital access and investor conviction. The rapid valuation increase provides additional financial flexibility for expansion.

Strategic Partnerships: Announcements in 2026 with organizations such as Atlantic Health and Priority Health indicate expanding distribution channels beyond direct employer sales. These relationships broaden market reach and embed the offering within health systems and plans.

Strong Revenue Growth: Company disclosures indicate annual recurring revenue increased in 2023, with higher‑margin recurring services expanding even faster, pointing to healthy momentum in the recurring mix.

Product Line Growth: Product expansion is evident with the 2025 launch of Vendavo AI and subsequent 2026 AI/ML feature releases, including a High‑Tech Revenue Management solution.

Market Expansion: An agreement in 2026 to acquire Model N’s High‑Tech business unit broadens capabilities into channel data management and semiconductor/high‑tech markets. New enterprise wins such as Dassault Aviation suggest a widening footprint.

Strong Hiring & Retention: Headcount is reported to have expanded by 32 in 2025, and current listings show multiple open roles across engineering, data, security, operations, and customer success. LinkedIn also shows roughly 85 employees, reinforcing sustained organizational growth.

Product Line Growth: Regulatory and product momentum includes FDA clearance of the eVO2peak Module in December 2025 and a portfolio the company describes as 12 cardiovascular digital biomarkers (8 FDA-cleared, 4 clinically validated). This indicates an expanding set of regulated and validated offerings on its platform.

Strategic Partnerships: Integration into Kardigan following the 2025 acquisition connects the platform to an active cardiovascular drug-development pipeline and clinical programs. SEC disclosures outline Prolaio-related patient and revenue milestones and describe deployment in Kardigan’s trials.

Strong Revenue Growth: Feedback suggests recurring revenue expanded from crossing $500M ARR in 2023 to “approaching $600M” by May 2024. These company disclosures indicate meaningful momentum in subscription scale.

Product Line Growth: Feedback suggests the portfolio has broadened via acquisitions and new capabilities—including Pearl Street Technologies (grid interconnection), Spatial Business Systems (utility design automation), PDS Energy exchange platforms, and TGS’s A2D well‑log library. Enverus also cites rapid uptake of newer AI products and substantial growth in power and renewables since 2021.

Investor Backing & Capital Strength: Feedback suggests capital support is robust, with Blackstone agreeing in 2025 to acquire Enverus in a transaction reported around $6–6.5 billion. This major third‑party deal signals external validation of scale and resources for the next growth phase.

Profitability: Adjusted EBITDA and margins expanded, with Q2 2026 EBITDA up 30% year over year and margin improving to 37%, alongside higher net income. This pattern indicates operating leverage as earnings outpace the top line.

Strong Revenue Growth: Revenue rose 7% in 2025 and accelerated to 11% year over year in Q2 2026, with multiple sequential quarters showing improving trends. The recent trajectory points to faster growth rather than a flat profile.

Healthy Cash Flow: Free cash flow is guided to grow at more than 30% for 2026 and was later raised to the high-40% range, while Q2 2026 generated $57.4M in operating cash. Debt reduction in 1H 2026, including repayment of $205M in convertibles, further supports balance-sheet strength.

Strong Revenue Growth: Revenue has risen strongly across 2025–2026, with the latest quarter marking the company’s 11th consecutive period of top-line expansion. Momentum is driven by continued gains in its Core Advertising business.

Profitability: Adjusted EBITDA expanded materially, with margins improving alongside scale, indicating solid operating leverage. Recent quarters show profitability strengthening even as the business invests for growth.

Healthy Cash Flow: Operating and free cash flow increased sharply on a trailing twelve‑month basis. Cash generation supports reinvestment and a stronger balance sheet following debt reduction.

Investor Backing & Capital Strength: Capital raising has accelerated, including a $372M Series D in 2024 with total funding reported in the hundreds of millions to expand the pipeline and AI platform. Valuation has stepped up from roughly $1.04B (2021) to about $1.48B post‑money (2024), signaling strengthened private‑market positioning.

Strategic Partnerships: Partnerships are expanding, highlighted by a collaboration with Sanofi and OpenAI to build AI software for drug development and increased business‑development capacity via Entrepreneurs in Residence. Engagements with large pharma partners, including Sanofi, underscore growing external validation and deal flow.

Product Line Growth: The pipeline is broadening through multiple in‑licenses—such as an anti‑CD226 program, a CNS‑penetrant TYK2 inhibitor, and a miR‑124 activator—and progression to first‑in‑human dosing of BLKR201 in 2026. Stated plans to reach 10–15 assets over 3–5 years align with recent portfolio expansion and clinical advancement.

Investor Backing & Capital Strength: Funding includes a $70M Series C in May 2025 with participation from firms such as a16z, Sequoia, Redpoint, and Snowflake Ventures. This indicates substantial investor confidence and available capital to scale.

Market Expansion: Customer reach is described as 2,000+ organizations, up from 1,500+ teams in May 2025, and the company highlights success with enterprises of 2,500+ employees (e.g., Toast, Cruise, Rivian). This suggests movement beyond smaller data teams into larger enterprise adoption.

Product Line Growth: The platform added embedded analytics in 2025 and is centering on AI-powered analytics with its Notebook Agent, while also broadening BI surface area via the Hashboard acquisition. These additions expand addressable use cases from internal notebooks to embedded and agentic analytics.

Innovation-Driven Growth: The company has expanded beyond visibility into AI-driven supply-chain execution with an Intelligent Control Tower, digital twins, and a digital workforce of AI agents. Independent write-ups also describe these 2024–2026 product moves, indicating a significant broadening of the offering.

Strong Market Position & Advantage: Materials describe a large global footprint (1,600+ enterprise customers, 3M+ daily shipments across 200+ countries) and repeated Leader recognition through 2024, with additional 2026 control-tower leadership mentions. These signals point to durable competitive positioning in core markets.

Strong Revenue Growth: Reported FY25 results for FourKites India show revenue of ₹147.4 crore, up 18.5% year over year, with profit also rising. While subsidiary-specific, this is clear, recent evidence of financial growth in a significant operating unit.

Strong Revenue Growth: Revenue is consistently climbing across 2025 and into 2026, with management increasing full‑year guidance after stronger‑than‑expected quarters. Momentum is led by U.S. Financial Services and Emerging Verticals, with multiple quarters of high single‑ to double‑digit organic growth noted.

Profitability: Net income and adjusted earnings expanded alongside revenue, and adjusted EBITDA also increased. This points to improving operating leverage as growth scales across key segments.

Diversified Revenue Streams: Multiple business lines—including credit, fraud/identity, marketing, and international operations—are contributing to results. Expansion such as taking majority ownership in the Mexico bureau and broad-based U.S. segment strength reduce reliance on any single product or geography.

Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.

Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.

Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.

Strong Revenue Growth: Recent results indicate FY2026 revenue rose 19% year over year to roughly $2.02B, with Q1 FY2027 revenue up 16% and ARR up 17%. This points to steady double‑digit expansion across both total and recurring revenue.

Customer Loyalty & Retention: Dollar-based net retention is reported around 110–111%, and ARR growth has tracked slightly ahead of revenue growth. These signals suggest existing customers are expanding usage alongside new logo additions.

Healthy Cash Flow: Company materials highlight strong free cash flow alongside growth, including substantial FY2026 free cash flow and robust margins in recent quarters. The business has also returned capital via notable share repurchases.

Investor Backing & Capital Strength: A $100M minority investment from Blackstone Growth in 2026, with reporting around a ~$700M valuation, signals substantial external capital support. Available information indicates this backing is intended to fund continued technology development and expansion.

Strong Hiring & Retention: Headcount is described as scaling into the hundreds by 2025–2026, alongside rapid hiring and multiple senior leadership additions. This trajectory points to purposeful organizational build-out to meet growing demand.

Market Expansion: Offerings have broadened from political/advocacy roots into corporate communications, investor relations, B2B marketing, and public affairs. Company materials indicate adoption across more than 100 Fortune 500 organizations and major agencies/trade groups.

Profitability: The company is described as privately held, profitable, and debt-free, indicating a solid financial base. This positioning supports continued investment without reliance on external financing.

Strong Revenue Growth: Revenue is reported above $1 billion with indications of year-over-year increases into 2024 and sustained scale into FY2025, while cloud segments are noted as expanding strongly. These signals point to ongoing top-line momentum.

Market Expansion: Operations span 28 countries with 38 offices serving customers in 80+ countries, alongside recent moves such as a dedicated public-sector subsidiary and added international presence. This footprint suggests continued geographic and channel growth.